Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1992-7-29
|
pubmed:abstractText |
Steady state c-myc mRNA levels determined by Northern blot analysis were examined in non-Hodgkin's lymphomas (NHL) of both high (n = 29) and low malignancy (n = 18), and in non-specific chronic lymphadenitis (n = 6). High grade NHL, classified according to the updated Kiel classification, revealed significantly larger amounts of c-myc mRNA compared with low grade NHL and lymphadenitis. mRNA levels in non-specific lymphadenitis were lower than in low grade NHL, but the differences were not statistically significant. No correlation between c-myc mRNA levels and the immunologic phenotype was discernible. Growth fractions of the NHL were determined by immunostaining with the monoclonal antibody Ki-67. Significant correlations between the percentages of Ki-67-positive cells, as well as the amounts of c-myc mRNA, and classification into high or low grade NHL were found. However, the percentage of Ki-67 positive cells and c-myc mRNA levels in individual cases and in the various histologic entities of NHL did not correlate. Our results indicate the overexpression of the c-myc gene in NHL, and a highly significant correlation of steady state c-myc mRNA levels with the prognosis-related histomorphologic Kiel classification of NHL into different subgroups of low and high grade malignancy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-6075
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:geneSymbol |
N-myc,
c-myc
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1352077-Antigens, Neoplasm,
pubmed-meshheading:1352077-Blotting, Northern,
pubmed-meshheading:1352077-Cell Division,
pubmed-meshheading:1352077-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:1352077-Genes, myc,
pubmed-meshheading:1352077-Humans,
pubmed-meshheading:1352077-Ki-67 Antigen,
pubmed-meshheading:1352077-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:1352077-Lymphadenitis,
pubmed-meshheading:1352077-Lymphoma, Non-Hodgkin,
pubmed-meshheading:1352077-Nuclear Proteins,
pubmed-meshheading:1352077-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:1352077-RNA, Messenger,
pubmed-meshheading:1352077-RNA, Neoplasm,
pubmed-meshheading:1352077-Tumor Markers, Biological
|
pubmed:year |
1992
|
pubmed:articleTitle |
c-myc mRNA expression in non-Hodgkin's lymphomas.
|
pubmed:affiliation |
Institute of Pathology, Technische Universität München, School of Medicine, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|